Nutex Health (NUTX) Stock Price, News & Analysis

Company Overview

Nutex Health is a Houston-based healthcare company with two main divisions: a Hospital Division and a Management Services Organization (MSO). Its Hospital Division develops and operates micro-hospitals that provide emergency care and other hospital and outpatient services.

Through its MSO, Nutex provides administrative, technology, analytics and other management support to affiliated physician-led organizations. These services support care coordination and population health management.

Founded by physician Thomas Vo, who serves as the company’s chairman and chief executive officer, Nutex operates in the United States. The company became publicly traded in 2022 following a merger with Clinigence Holdings.

Key Stats

• Today's Range: $187.00 to $196.69
• 50-Day Range: $179.58 to $225.00
• 52-Week Range: $83.99 to $226.16
• Volume: 98,627 shs
• Average Volume: 135,870 shs
• Market Capitalization: $1.30 billion
• P/E Ratio: 7.95
• Dividend Yield: N/A
• Price Target: $342.00
• Consensus Rating: Moderate Buy

Nutex Health Stock Analysis - MarketRank™

Nutex Health scored higher than 76% of companies evaluated by MarketBeat, and ranked 120th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Nutex Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on no strong buy ratings, 4 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

Nutex Health has a consensus price target of $342.00, representing about 80.8% upside from its current price of $189.19.

Amount of Analyst Coverage

Nutex Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: -5.38%

Earnings Growth

Earnings for Nutex Health are expected to decrease by -5.38% in the coming year, from $27.70 to $26.21 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Nutex Health is 7.95, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.70.

Price to Earnings Ratio vs. Sector

The P/E ratio of Nutex Health is 7.95, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 33.90.

Price to Book Value per Share Ratio

Nutex Health has a P/B Ratio of 2.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

30.74% of the float of Nutex Health has been sold short.

Short Interest Ratio / Days to Cover

Nutex Health has a short interest ratio ("days to cover") of 10.09, which indicates bearish sentiment.

Change versus previous month

Short interest in Nutex Health has recently decreased by 5.86%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Nutex Health does not currently pay a dividend.

Dividend Growth

Nutex Health does not have a long track record of dividend growth.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.65

News Sentiment

Nutex Health has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 18 news articles for Nutex Health this week, compared to 3 articles on an average week.

Search Interest

Only 8 people have searched for NUTX on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.

MarketBeat Follows

3 people have added Nutex Health to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Nutex Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $43,493.00 in company stock.

Percentage Held by Insiders

44.68% of the stock of Nutex Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

5.32% of the stock of Nutex Health is held by institutions.

Company Calendar

• Last Earnings: 11/05/2026
• Today: 11/11/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Facilities
• Current Symbol: NASDAQ:NUTX
• CIK: 1479681
• Web: www.nutexhealth.com
• Phone: (713) 660-0557
• Fax: 631-670-6780
• Employees: 944
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Nutex Health: $342.00
• High Price Target: $357.00
• Low Price Target: $333.00
• Potential Upside/Downside: +80.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.80
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): $23.42
• Trailing P/E Ratio: 7.95
• Forward P/E Ratio: 7.22
• P/E Growth: N/A
• Net Income: $70.79 million
• Net Margins: 20.68%
• Pretax Margin: 36.67%
• Return on Equity: 34.43%
• Return on Assets: 17.01%

Debt

• Debt-to-Equity Ratio: 0.59
• Current Ratio: 4.76
• Quick Ratio: 4.96

Sales & Book Value

• Annual Sales: $875.26 million
• Price / Sales: 1.48
• Cash Flow: $13.12 per share
• Price / Cash Flow: 14.42
• Book Value: $78.84 per share
• Price / Book: 2.40

Miscellaneous

• Outstanding Shares: 6,860,000
• Free Float: 3,796,000
• Market Cap: $1.30 billion
• Optionable: Not Optionable
• Beta: 0.66